Skip to content
healthcare.dev
Get a free key

Doxazosin mesylate

NDC 59762-1391, doxazosin mesylate, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
59762-1391
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA019668
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1391 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE8 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
59762-1391-759762139107100 TABLET in 1 BOTTLE (59762-1391-7)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e524986-7903-416f-b2b8-d27295103e75

  • NADAC price for package 59762139107

    GET /v1/drugs/nadac/59762139107

Use it

Look up 59762-1391 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1391 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59762-1391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.